Recipients of allogeneic stem cell transplantation, including bone marrow, peripheral blood, or cord blood transplantation
Conditions
Interventions
None listed
Sponsors
Department of Hematology, Oita University Hospital.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Recipients of allogeneic stem cell transplantation treated in our hospital
Exclusion criteria
Exclusion criteria: Patients who didn't agree to participation and patients who were judged as inadequate to participate in this study by the opinion of the investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Positive rate for HHV-6 DNA | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Antiviral agents 2. Association between the results of blood HHV-6 DNA and the development of HHV-6 encephalitis 3. Sensitivity, specificity, positive predictive value, and negative predictive value of positive results for HHV-6 DNA for the diagnosis of HHV-6 encephalitis 4. Association between the results of HHV-6 DNA in cerebrospinal fluid and the development of HHV-6 encephalitis | — |
Countries
Japan
Contacts
Public ContactMasao Ogata
Oita University Hospital Hematology
Outcome results
None listed